More Than 500 Pharmas Suspended For Failure To Meet GMP Standards
This article was originally published in PharmAsia News
Executive Summary
More than 500 non-qualified manufacturers of sterile drugs have been suspended since Jan. 1, including those that make blood products, vaccines and injections for failing to meet the standards of new good manufacturing practices by the end of last year.